Vancomycin MIC for methicillin-resistant coagulase-negative Staphylococcus isolates: Evaluation of the broth microdilution and etest methods

Journal of Clinical Microbiology

Volumn 48, Issue 12, 2010, Pages 4652-4654

  Paiva, Rodrigo M ^a   Mombach Pinheiro Machado, Alice B ^a   Zavascki, Alexandre P ^a   Barth, Afonso L ^a,b  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BROTH DILUTION; COAGULASE NEGATIVE STAPHYLOCOCCUS; EPSILOMETER TEST; INTERMETHOD COMPARISON; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS HAEMOLYTICUS; STAPHYLOCOCCUS HOMINIS;

BACTEREMIA; COAGULASE; HOSPITALS; HUMANS; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS; VANCOMYCIN;

STAPHYLOCOCCUS;

EID: 78650060592     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01182-10     Document Type: Article

References (19)

1. Bannerman, T. L., and S. J. Peacock. 2007. Staphylococcus, micrococcus, and other catalase-positive cocci, p. 390-411. In P. R. Murray, E. J. Baron, M. A. Pfaller, J. H. Jorgensen, and M. L. Landry (ed.), Manual of clinical microbiology, 9th ed. ASM Press, Washington, DC.
2. Center, K. J., A. C. Reboli, R. Hubler, G. L. Rodgers, and S. S. Long. 2003. Decreased vancomycin susceptibility of coagulase-negative staphylococci in a neonatal intensive care unit: evidence of spread of Staphylococcus warneri. J. Clin. Microbiol. 41:4660-4665.
3. Clinical and Laboratory Standards Institute. 2008. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard, 8th ed. CLSI document M07-A8. Clinical and Laboratory Standards Institute, Wayne, PA.
4. Diekema, D. J., M. A. Pfaller, F. J. Schmitz, J. Smayevsky, J. Bell, R. N. Jones, M. Beach, and the SENTRY Participants Group. 2001. Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin. Infect. Dis. 32:S114-S132.
5. Gales, A. C., H. S. Sader, J. Ribeiro, C. Zoccoli, A. Barth, and A. C. Pignatari. 2009. Antimicrobial susceptibility of Gram-positive bacteria isolated in Brazilian hospitals participating in the SENTRY program (2005-2008). Braz. J. Infect. Dis. 13:90-98.
6. Garrett, D. O., E. Jochimsen, K. Murfitt, B. Hill, S. McAllister, P. Nelson, R. V. Spera, R. K. Sall, F. C. Tenover, J. Johnston, B. Zimmer, and W. R. Jarvis. 1999. The emergence of decreased susceptibility to vancomycin in Staphylococcus epidermidis. Infect. Control Hosp. Epidemiol. 20:167-170.
7. Hope, R., D. M. Livermore, G. Brick, M. Lillie, and R. Reynolds on behalf of the BSAC Working Parties on Resistance Surveillance. 2008. Non-susceptibility trends among staphylococci from bacteraemias in the UK and Ireland, 2001-06. J. Antimicrob. Chemother. 62:ii65-ii74.
8. Hsu, D. I., L. K. Hidayat, R. Quist, J. Hindler, A. Karlsson, A. Yusof, and A. Wong-Beringer. 2008. Comparison of method-specific vancomycin minimum inhibitory concentration values and their predictability for treatment outcome of methicillin-resistant Staphylococcus aureus (MRSA) infections. Int. J. Antimicrob. Agents 32:378-385.
9. Jones, R. N. 2006. Microbiological features of vancomycin in the 21st century: minimum inhibitory concentration creep, bactericidal/static activity, and applied breakpoints to predict clinical outcomes or detect resistant strains. Clin. Infect. Dis. 42:S13-S24.
10. Martineau, F., F. J. Picard, P. H. Roy, M. Ouellette, and M. G. Bergeron. 1996. Species-specific and ubiquitous DNA-based assays for rapid identification of Staphylococcus epidermidis. J. Clin. Microbiol. 34:2888-2893.
11. Mason, E. O., L. B. Lamberth, W. A. Hammerman, K. G. Hulten, J. Versalovic, and S. L. Kaplan. 2009. Vancomycin MICs for Staphylococcus aureus vary by detection method and have subtly increased in a pediatric population since 2005. J. Clin. Microbiol. 47:1628-1630.
12. Moise-Broder, P. A., G. Sakoulas, G. M. Eliopoulos, J. J. Schentag, A. Forrest, and R. C. Moellering, Jr. 2004. Accessory gene regulator group II polymorphism in methicillin-resistant Staphylococcus aureus is predictive of failure of vancomycin therapy. Clin. Infect. Dis. 38:1700-1705.
13. Mombach Pinheiro Machado, A. B., K. C. Reiter, R. M. Paiva, and A. L. Barth. 2007. Distribution of staphylococcal cassette chromosome mec (SC-Cmec) types I, II, III and IV in coagulase-negative staphylococci from patients attending a tertiary hospital in southern Brazil. J. Med. Microbiol. 56:1328-1333.
14. Prakash, V., J. S. Lewis II, and J. H. Jorgensen. 2008. Vancomycin MICs for methicillin-resistant Staphylococcus aureus isolates differ based upon the susceptibility test method used. Antimicrob. Agents Chemother. 52:4528.
15. Sader, H. S., P. R. Rhomberg, and R. N. Jones. 2009. Nine-hospital study comparing broth microdilution and Etest method results for vancomycin and daptomycin against methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 53:3162-3165.
16. Sakoulas, G., P. A. Moise-Broder, J. Schentag, A. Forrest, R. C. Moellering, Jr., and G. M. Eliopoulos. 2004. Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia. J. Clin. Microbiol. 42:2398-2402.
17. Srinivasan, A., J. D. Dick, and T. M. Perl. 2002. Vancomycin resistance in staphylococci. Clin. Microbiol. Rev. 15:430-438.
18. Swenson, J. M., K. F. Anderson, D. R. Lonsway, A. Thompson, S. K. McAllister, B. M. Limbago, R. B. Carey, F. C. Tenover, and J. B. Patel. 2009. Accuracy of commercial and reference susceptibility testing methods for detecting vancomycin-intermediate Staphylococcus aureus. J. Clin. Microbiol. 47:2013-2017.
19. Tacconelli, E., M. Tumbarello, K. G. Donati, M. Bettio, T. Spanu, F. Leone, L. A. Sechi, S. Zanetti, G. Fadda, and R. Cauda. 2001. Glycopeptide resistance among coagulase-negative staphylococci that cause bacteremia: epidemiological and clinical findings from a case-control study. Clin. Infect. Dis. 33:1628-1635.